United States Drug Enforcement Administration

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...

NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a nonprofit healthcare system that owns and operates a network of healthcare entities has agreed to pay $150,000...

WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...

TRENTON, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Susan A. Gibson, and U.S. Attorney for the District of New Jersey, Craig Carpenito, announced a New York doctor today admitted distributing opioids without a legitimate medical reason and soliciting sexual favors from patients in...

CAMDEN, N.J. – DEA New Jersey Division Special Agent in Charge Susan A. Gibson and U.S. Attorney for the District of New Jersey Craig Carpenito announced a Pennsylvania woman was sentenced today to 19 months in prison for unlawfully distributing prescription opioid pain medication in the Philadelphia and South Jersey...

NEW ORLEANS – Morris & Dickson Company LLC has agreed to pay the United States $22 million in civil penalties to resolve claims that it violated the Controlled Substances Act by failing to report suspicious orders of hydrocodone and oxycodone, announced Drug Enforcement Administration Special Agent in Charge Brad L...

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...